Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genzyme, a Sanofi Company
One to 70 days, as screening and inclusion visit(s) were performed the same day or on separate days with a maximum timeframe of 30 days apart. One visit was required for blood draw. However, if a second visit occured, it took place within 40 days of the first visit.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female adult participants who had been treated with LEMTRADA, with development of ITP subsequent to treatment. Participants does not need to be currently on LEMTRADA treatment.
Participants who had signed the study ICF.
You may not be if
\- Not applicable
The above information was not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.
